915 related articles for article (PubMed ID: 30521551)
1. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
2. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
3. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
[TBL] [Abstract][Full Text] [Related]
5. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.
Vernocchi P; Del Chierico F; Quagliariello A; Ercolini D; Lucidi V; Putignani L
Nutrients; 2017 Dec; 9(12):. PubMed ID: 29232848
[TBL] [Abstract][Full Text] [Related]
6. The Microbiome in Cystic Fibrosis Pulmonary Disease.
Françoise A; Héry-Arnaud G
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403302
[TBL] [Abstract][Full Text] [Related]
7. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
[TBL] [Abstract][Full Text] [Related]
8. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
[TBL] [Abstract][Full Text] [Related]
9. An
Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JL; O'Toole GA
J Bacteriol; 2024 Jan; 206(1):e0028623. PubMed ID: 38169295
[TBL] [Abstract][Full Text] [Related]
10. CFTR dysregulation drives active selection of the gut microbiome.
Meeker SM; Mears KS; Sangwan N; Brittnacher MJ; Weiss EJ; Treuting PM; Tolley N; Pope CE; Hager KR; Vo AT; Paik J; Frevert CW; Hayden HS; Hoffman LR; Miller SI; Hajjar AM
PLoS Pathog; 2020 Jan; 16(1):e1008251. PubMed ID: 31961914
[TBL] [Abstract][Full Text] [Related]
11. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
[TBL] [Abstract][Full Text] [Related]
12. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
Madan JC
Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296
[TBL] [Abstract][Full Text] [Related]
13. Lung and Gut Microbiota Changes Associated with
Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
[TBL] [Abstract][Full Text] [Related]
14. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis.
Li L; Krause L; Somerset S
Clin Nutr; 2017 Aug; 36(4):1097-1104. PubMed ID: 27595636
[TBL] [Abstract][Full Text] [Related]
15. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
16. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.
Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2016 May; 6():24857. PubMed ID: 27143104
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
18. The gut-lung axis in the CFTR modulator era.
Lussac-Sorton F; Charpentier É; Imbert S; Lefranc M; Bui S; Fayon M; Berger P; Enaud R; Delhaes L
Front Cell Infect Microbiol; 2023; 13():1271117. PubMed ID: 37780857
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.
Coffey MJ; Nielsen S; Wemheuer B; Kaakoush NO; Garg M; Needham B; Pickford R; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2019 Dec; 9(1):18593. PubMed ID: 31819107
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
